Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...
Hatched in local ponds and living among garden plantings, these cousins of the dragonfly captured the photographer’s attention and imagination. Left: A damselfly—one of photographer Remus Tiplea’s ...
About Dragonfly Energy Holdings Corp. Dragonfly Energy Holdings Corp. engages in the manufacture and supply of deep cycle lithium-ion batteries. It also focuses on delivering an energy storage ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results